Biovica signs US agreement with leading healthcare provider in Arizona

19 September 2023 - 09:00

Biovica today announces that the company has entered into a commercial agreement with a leading healthcare provider that operates more than 30 hospital laboratories, primarily located in Arizona. The agreement will ensure access to DiviTum® TKa for patients across the partners extensive network covering the southwest region of the United States. This agreement marks Biovica’s first commercial hospital (client bill) agreement.

“We are thrilled to be partnering with this leading healthcare provider and their affiliates. This agreement enables both widespread awareness and access to DiviTum® TKa for patients in the southwest region of the United States.” said Warren Cresswell, President of the Americas at Biovica.

Provided by: MFN
Nasdaq First North GM Stockholm (Sweden)
Biovica International AB
Biovica is a biotech company which develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More